MITF: master regulator of melanocyte development and melanoma oncogene
Top Cited Papers
- 1 September 2006
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 12 (9), 406-414
- https://doi.org/10.1016/j.molmed.2006.07.008
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Use of human tissue to assess the oncogenic activity of melanoma-associated mutationsNature Genetics, 2005
- Tbx2 Is Overexpressed and Plays an Important Role in Maintaining Proliferation and Suppression of Senescence in MelanomasCancer Research, 2005
- Pax3 functions at a nodal point in melanocyte stem cell differentiationNature, 2005
- Apoptosis and melanoma chemoresistanceOncogene, 2003
- Mutations of the BRAF gene in human cancerNature, 2002
- Microphthalmia Transcription Factor Is a Target of the p38 MAPK Pathway in Response to Receptor Activator of NF-κB Ligand SignalingJournal of Biological Chemistry, 2002
- Linkage of M-CSF Signaling to Mitf, TFE3, and the Osteoclast Defect in Mitfmi/mi MiceMolecular Cell, 2001
- The Transcription Factor Onecut-2 Controls the Microphthalmia-Associated Transcription Factor GeneBiochemical and Biophysical Research Communications, 2001
- The Gene Encoding the T-box Factor Tbx2 Is a Target for the Microphthalmia-associated Transcription Factor in MelanocytesPublished by Elsevier ,2000
- The Hallmarks of CancerCell, 2000